A pan-cancer target like fibroblast activation protein or FAP may seem like science fiction, but it is widely considered to be one of the most promising targets for both cancer imaging and therapy. Follow the link to read our interactive FAP explainer and learn more about the potential of this target and Telix’s theranostic approach: https://bit.ly/48UGrkE
Telix Pharmaceuticals Limited’s Post
More Relevant Posts
-
Miltos Krokidis' article tip! Can radiomics predict TARE outcomes? Read this interesting single-centre study on 51 patients who underwent TARE for the treatment on colorectal cancer metastases assessing the use of radiomic features from pre-treatment imaging. The study reveals that the CT radiomics model may predict response and survival outcomes. https://lnkd.in/dJf8CwiY
-
-
Can you guess what is inside the egg ? 🥚 Our X-Rays specialist Francesca Mastropietro is helping you by using an X-Rays imaging system. The X-Rays imaging system allows us to use the penetration property of this electromagnetic radiation so we can see inside objects. This can be particularly useful for medical applications such as early detection of breast cancer. 🎗 #XRayApplication #PhotonicsForHealth #HappyEaster
-
In this video, a breast cancer tissue micro array is labeled using CD68, PanCK, CD8, Granzyme B, CD3, Ki67, PDL1, CD45ro, PD-1, MHC-II, CD11b, and CD20. The tissue was labeled and imaged using Visikol's multiplex tissue imaging approach. To learn more about our multiplex services, click here --> https://hubs.ly/Q02WkMgG0 #Visikol #Multiplex #TissueImaging
-
Teaching Assistant, Radiological Sciences Department, Imam Abdulrahman Bin Faisal University
I am thrilled to have had the opportunity to present at the School of Medicine Symposium on the advancements in prostate cancer detection. My presentation focused on the cutting-edge research in photoacoustic imaging and its potential in enhancing diagnostic accuracy and intervention strategies for prostate cancer. #MedicalImaging #ProstateCancer #PhotoacousticImaging #CancerDetection #MedicalResearch
-
Ever wondered what could possibly deter cell-based immunotherapy success in solid tumors? Jiranuwat Sapudom and Aseel Alatoom are co first authors in this manuscript published in #biomaterials where they showed aligned tissue microarchitecture, as observed in solid cancer stroma, suppresses #tcell response! #immunomechanobiology #cancerimmunology Great effort! Many thanks to Mostafa Khair Rachid Rezgui PhD from #nyuad Core Technology Platforms for supporting this work https://lnkd.in/dUxPMjfU
-
-
Medical Physicist, Radiation Oncology @RCC,|RSO| Visiting Lecturer, University of Rwanda- CMHS|
Moving targets in radiation therapy (RT) pose challenges that can result in uncertainties and negative outcomes. However, advanced technologies have been developed to effectively manage tumor motion. Some of these technologies, which improve the precision and reliability of treatment, include gating, breath-hold techniques, and tumor tracking, as demonstrated in the attached video. #Courtesy, Rayos Contra Cancer #precision, #oncology, #Medicalphysics, #Education,
-
Right now the risk of a false negative in a líquid biopsy Is plausible because of ctDNA, specially in early stages. This articule goes deeper on working in these Challenges.
Using two different techniques, researchers showed they could temporarily boost ctDNA levels in the blood of mice with tumors. With more ctDNA in collected blood draws, a liquid biopsy could better detect cancer, the research team found. https://go.nih.gov/dIlIcBu
-
-
💗 This one hits close to home. 🔬 A traditional, invasive tissue biopsy may only capture information about one "subclone" within a heterogenous and dynamic tumor. By contrast, a liquid biopsy is minimally invasive and offers a longitudinal picture of a tumor via cfDNA analysis. 🧾 Read more about how researchers like Dr. Karen Page are setting the stage for the era of the liquid biopsy and tracking tumor evolution through the entire cancer journey: https://lnkd.in/gzCFn4dn
-
-
As we observe Prostate Cancer Awareness Month this September, United Imaging is proud to be at the forefront of advanced medical imaging technology that's making a difference in prostate cancer detection and treatment. Prostate Cancer: A Critical Health Issue • Affects 1 in 8 men during their lifetime • Second most common cancer in men globally • Early detection is key to successful outcomes At United Imaging, we're committed to revolutionizing prostate cancer care through our cutting-edge imaging solutions. Our state-of-the-art PET/CT scanners, including the uMI 780, offer exceptional image quality and sensitivity, enabling clinicians to detect prostate cancer with unprecedented accuracy. Our Technology, Your Health Our advanced imaging systems support: • Earlier and more precise detection • Improved treatment planning • Enhanced patient outcomes We're proud to collaborate with leading healthcare providers and research institutions to continually push the boundaries of what's possible in prostate cancer imaging and care. Join us in raising awareness about prostate cancer. Share this post to encourage regular screenings and support those affected by this disease. #ProstateCancerAwarenessMonth #MedicalImaging #UnitedImaging #InnovationInHealthcare
Molecular imaging can give prostate cancer patients the clearest and most precise picture of where cancer is located. A radiotracer seeks out the cancer cells, and our advanced PET scanners capture the tracer's signals to produce an image. Dr. Harshad Kulkarni explains it further in this latest video. #ProstateCancerAwarenessMonth #ProstateCancer #MolecularImaging
-
A very in depth article i you want to get up to speed with liquid biopsies and their current state of play. An exciting future awaits us! MCED tests promise to transform the detection of cancer. In this new white paper, RGA explores what this could mean for insurers and the challenges of modeling and quantifying MCED tests' potential impact. https://lnkd.in/eRbVw8qc
-
